Where to Buy NAD+: One Bulk Market, Very Different Bills

This site usually reports that a compound has one route and four dead ends. NAD+ is the exception, and it deserves a different structure. It is a coenzyme rather than an investigational drug, it has an open clinic market, it can be compounded for a prescriber, and it is also sold by the gram as laboratory research material. Five channels, all functioning, all charging wildly different amounts for material that started life in the same industrial supply chain.

That last point is the one worth holding onto while you read the rest. Bulk nicotinamide adenine dinucleotide is manufactured at scale and moves through distributors and repackagers before anyone downstream decides what to do with it. FDA has said in writing that it "is aware of compounders using food-grade nicotinamide adenine dinucleotide (NAD+) sold by repackagers to make intravenous products." So the fact that a licensed business handled your material is not by itself evidence about the grade of the powder. What the business demanded of its supplier is.

We earn a commission on one of the five channels below, which our affiliate disclosure explains in full. It is the cheapest channel and the one with the least accountability attached, and this page says so in both directions.

This is the channel most readers have already seen advertised, on a sandwich board or an Instagram ad, usually alongside vitamin drips and hangover packages. It is also the only channel in this comparison where somebody is in the room with you while the material goes in, which is worth real money and is the reason the price is what it is.

What you are buying is a service. The session price covers the preparation, the sterile handling, the chair, the staff time, the practice's insurance and the premises, and the raw material inside the bag is a small fraction of it. Pricing is normally quoted per session, with a loading course of several sessions sold as a package up front and maintenance sessions after that, so the number you commit to is usually a multiple of the number on the menu board. Our companion piece on NAD+ price works the arithmetic through properly.

The question to ask is not about price, it is about provenance. Ask which pharmacy prepared the preparation, whether the material is pharmaceutical grade, and whether the certificate reports bacterial endotoxins testing. FDA's notice to compounders, content current as of 30 October 2024, exists because those questions were not being asked: it records adverse event reports after NAD+ injectable drugs, including "severe chills, shaking, vomiting and fatigue with some requiring medical treatment," and says the reactions are "consistent with excessive levels of endotoxins." A clinic that answers all three cleanly has just distinguished itself. One that gets defensive has answered too.

This channel is real for NAD+ in a way it is not for most of what we cover, and the reason is a specific regulatory position. Nicotinamide adenine dinucleotide appears in category 1 of FDA's list of bulk drug substances nominated for use in compounding under section 503A, in the list updated 14 May 2026. Category 1 means FDA does not intend to take action against a compounder using the substance provided the conditions in its guidance are met. That is non-enforcement while evaluation is pending. It is not approval, and it is explicitly not permanent.

What it buys you is the sourcing rule underneath. A pharmacy compounding with a bulk substance has to use material accompanied by a valid certificate of analysis, manufactured by an establishment registered with FDA under section 510, as set out on FDA's bulk drug substances page. Nothing forces a research supplier to meet that standard. That difference is the entire argument for this channel.

The friction is that it needs a clinician willing to prescribe, and many will not, because there is no approved product and no dosing consensus to work from. It also costs prescription-channel money rather than raw-material money. If you want the accountability, this is where it lives, and our page on NAD+ without a prescription covers the legal detail.

The third channel sells NAD+ as a lyophilized powder labelled for laboratory research use only, not for human consumption. That label is the legal basis of the sale rather than a formality, which is why nothing in the box tells you what to do with the contents. It is also the channel with the price that makes people write to us: at the supplier we link, NAD+ 1,000 mg lists at $104.00 and costs $52.00 with the code PEPTIDEDECK, which is $5.20 per 100 mg.

Suppliers inside this channel vary more than their storefronts suggest. The ones worth an order publish a batch-specific certificate from a named laboratory, hold stock domestically with a published dispatch cutoff, take card payments, and keep human dosing content off the product pages. Ascension states two independent laboratories test every batch and dispatches same day before 2pm CST, and its quantity tiers take 3, 5 or 10 percent off list at three, five and ten units. Nothing published says the code stacks with those tiers, so treat them as alternatives.

The check that matters most in this channel is the one people skip. Open the certificate and look for bacterial endotoxins or LAL testing, reported in endotoxin units, rather than identity and purity alone. A sample can be 99 percent pure and still carry the contamination FDA describes, because a purity assay is not looking for it. Our full vetting sequence is on where to buy NAD+ as a research vial.

Search a little and you will find bulk NAD+ on large trade platforms and on standalone sites shipping from abroad, priced below anything domestic. Some of that material is genuinely from the manufacturers everyone else buys from. Some of it is the repackaged food-grade product FDA's notice is about, and the listing will not tell you which.

The structural problems are the same ones we describe for every compound. Certificates are frequently generic rather than lot-specific. You are the importer, so seizure and duty fall on you. Recourse across a border is theoretical. For NAD+ there is one extra: a gram of powder sitting in a customs queue for three weeks has spent three weeks somewhere nobody was watching the temperature, and cold-chain integrity is not something a certificate issued before shipping can speak to.

The price gap in this channel is rarely efficiency. Testing costs money and domestic warehousing costs money, and a seller doing neither can undercut one doing both. Cheap here usually means untested rather than lean, and our scam checker is built around exactly that pattern.

The fifth channel is the one people land in by accident. Search results and pharmacy shelves are full of capsules marketed around NAD+, and most of them do not contain NAD+ at all. They contain precursors, usually nicotinamide mononucleotide or nicotinamide riboside, which the body converts along its own pathways.

We are not going to tell you those do or do not work, and we are deliberately not stating their regulatory position, because it is a separate history from NAD+ and we have not verified it for this page. What we will say plainly is that it is a different purchase. An oral precursor capsule and a gram of injectable-intent NAD+ powder are not interchangeable, they are not priced against each other in any meaningful way, and a page that treats them as one product is not paying attention.

If the reason you are reading this is general energy and ageing marketing rather than a specific plan, this channel is the low-stakes end of the market and the one where a mistake costs the price of a bottle.

The table compresses the page. Read the accountability column before the price column, because that is the axis the price is actually tracking.

One note on the pricing column. We give a figure only where a published price exists to give. Clinic pricing is described structurally rather than numerically because we could not source a clinic price list that both resolves and is representative, and inventing a range to fill a column is how the rest of this niche got its numbers.

Where to buy NAD+ is a question about what you want to be true when something goes wrong. A clinic and a compounding pharmacy sell you a chain of accountable people, and the price reflects the chain. A research supplier sells you a gram of powder at $5.20 per 100 mg and no chain whatsoever. The material may well have started in the same place.

Whichever channel you use, the one question that travels across all five is whether anybody tested the material for endotoxins and can show you the result against your lot number. That is the question FDA's notice is really about, and it is the only one that separates a good outcome from the adverse events the agency describes. Ask it at the clinic desk, ask it of the pharmacy, and ask it of the vendor before you check out.